These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Yes, industry influence is excessive. Shah AA; Finucane TE Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608 [No Abstract] [Full Text] [Related]
11. Drug company-sponsored symposia: pros and cons. Finucane T Am J Med; 1987 Oct; 83(4):811-2. PubMed ID: 3674075 [No Abstract] [Full Text] [Related]
12. Trojan horse advertising. Friedman JH Med Health R I; 1999 May; 82(5):150. PubMed ID: 10343487 [No Abstract] [Full Text] [Related]
13. Publication ethics policies for medical journals. Pai SA Indian J Med Ethics; 2004; 1(3):93. PubMed ID: 16370089 [No Abstract] [Full Text] [Related]
14. College activities and the ethics of advertising. Ryan C; Walter G; Robertson M Australas Psychiatry; 2010 Apr; 18(2):101-5. PubMed ID: 20307152 [TBL] [Abstract][Full Text] [Related]
18. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective. Norris RA Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261 [No Abstract] [Full Text] [Related]
19. How to ensure our readers' trust: the proper attribution of authors and contributors. Liesegang TJ; Albert DM; Schachat AP Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976 [No Abstract] [Full Text] [Related]
20. Conflict of interest and special interest groups. The making of a counter culture. Fava GA Psychother Psychosom; 2001; 70(1):1-5. PubMed ID: 11150932 [No Abstract] [Full Text] [Related] [Next] [New Search]